Literature DB >> 28116813

Efficacy of flattening-filter-free beam in stereotactic body radiation therapy planning and treatment: A systematic review with meta-analysis.

Thu M Dang1, Mitchell J Peters1, Brigid Hickey1, Adam Semciw2.   

Abstract

A linear accelerator with the flattening-filter removed generates a non-uniform dose profile beam. We aimed to analyse and compare plan quality and treatment time between flattened beam (FB) and flattening-filter-free (FFF) beam to assess the efficacy of FFF beam for stereotactic body radiation therapy (SBRT). The search strategy was based around 3 concepts; radiation therapy, flattening-filter-free and treatment delivery. The years searched were restricted from 2010 to date of review (October 2015). All plan quality comparisons were between FFF and FB plans from the same data sets. We identified 210 potential studies based on the three searched concepts. All articles were screened by two authors for title and abstract and by three authors for full text. Ten studies met the eligibility criteria. Plan quality was evaluated using conformity index (CI), heterogeneity index (HI) and gradient index (GI). Dose to organs-at-risk (OAR) and healthy tissues were compared. Differences between beam-on-time (BOT) and treatment time (T × T) were also analysed. Normalized percentage ratios of CI and HI demonstrated no clinical differences among the studied articles. GI displayed small variations between the articles favouring FFF beam. The BOT with FFF is substantially reduced, and appears to impact the frequency of intra-fraction imaging which, in turn, affects total treatment time. Based on planning tumour volume (PTV) coverage, dose to OAR and healthy tissue sparing, FFF beam is clinically effective for the treatment of cancer patients using SBRT. We recommend the use of FFF beam for SBRT based on these factors and the reported overall treatment time reduction.
© 2017 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Keywords:  flattening-filter-free; radiation therapy; radiation treatment delivery; radiation treatment planning; stereotactic body radiation therapy

Mesh:

Year:  2017        PMID: 28116813     DOI: 10.1111/1754-9485.12583

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  10 in total

1.  In-vivo and in-vitro impact of high-dose rate radiotherapy using flattening-filter-free beams on the anti-tumor immune response.

Authors:  P A Laurent; A Kownacka; R Boidot; C Richard; E Limagne; V Morgand; L Froidurot; C Bonin; L Aubignac; F Ghiringhelli; G Créhange; C Mirjolet
Journal:  Clin Transl Radiat Oncol       Date:  2020-07-31

2.  Cellular Damage in the Target and Out-Of-Field Peripheral Organs during VMAT SBRT Prostate Radiotherapy: An In Vitro Phantom-Based Study.

Authors:  Igor Piotrowski; Katarzyna Kulcenty; Wiktoria Suchorska; Marcin Rucinski; Karol Jopek; Marta Kruszyna-Mochalska; Agnieszka Skrobala; Piotr Romanski; Adam Ryczkowski; Dorota Borowicz; Natalia Matuszak; Julian Malicki
Journal:  Cancers (Basel)       Date:  2022-05-30       Impact factor: 6.575

3.  Time motion study to evaluate the impact of flattening filter free beam on overall treatment time for frameless intracranial radiosurgery using Varian TrueBeam® linear accelerator.

Authors:  Gopinath Mamballikalam; S Senthilkumar; C O Clinto; P M Ahamed Basith; R C Jaon Bos; Tems Thomas
Journal:  Rep Pract Oncol Radiother       Date:  2021-02-25

Review 4.  Volumetric modulated arc therapy for treatment of solid tumors: current insights.

Authors:  Gabriella Macchia; Francesco Deodato; Savino Cilla; Silvia Cammelli; Alessandra Guido; Martina Ferioli; Giambattista Siepe; Vincenzo Valentini; Alessio Giuseppe Morganti; Gabriella Ferrandina
Journal:  Onco Targets Ther       Date:  2017-07-26       Impact factor: 4.147

5.  Effect of dose-delivery time for flattened and flattening filter-free photon beams based on microdosimetric kinetic model.

Authors:  Hisashi Nakano; Daisuke Kawahara; Kaoru Ono; Yukio Akagi; Yutaka Hirokawa
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

6.  Intrafractional motion in stereotactic body radiotherapy of spinal metastases utilizing cone beam computed tomography image guidance.

Authors:  Jørund Graadal Svestad; Christina Ramberg; Birgitte Skar; Taran Paulsen Hellebust
Journal:  Phys Imaging Radiat Oncol       Date:  2019-11-02

7.  Impact of tumor size and location on lung dose difference between stereotactic body radiation therapy techniques for non-small cell lung cancer.

Authors:  Seong Soon Jang; Yohan Shin; Suk Young Park; Gil Ja Huh; Young Jun Yang
Journal:  Thorac Cancer       Date:  2021-10-24       Impact factor: 3.500

8.  Impact of Dosimetric Parameters on Interplay Effects in 6 MV Flattening Filter-Free Photon Beams to Treat Lung Cancer.

Authors:  Vanida Poolnapol; Taweap Sanghangthum; Mintra Keawsamur
Journal:  J Med Phys       Date:  2022-03-31

9.  Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer.

Authors:  Christoph Oehler; Nina Roehner; Marcin Sumila; Jürgen Curschmann; Fabrizio Storelli; Daniel Rudolf Zwahlen; Uwe Schneider
Journal:  Curr Oncol       Date:  2022-08-31       Impact factor: 3.109

10.  Improving function in people with hip-related pain: a systematic review and meta-analysis of physiotherapist-led interventions for hip-related pain.

Authors:  Joanne L Kemp; Andrea B Mosler; Harvi Hart; Mario Bizzini; Steven Chang; Mark J Scholes; Adam I Semciw; Kay M Crossley
Journal:  Br J Sports Med       Date:  2020-05-06       Impact factor: 13.800

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.